Zymeworks (ZYME) Receivables - Net (2021 - 2026)
Zymeworks' (ZYME) quarterly Receivables - Net came in at $4.7 million in Q1 2026, down 81.0% year-on-year from $24.6 million in Q1 2025, and up 0.78% quarter-over-quarter from $4.6 million in Q4 2025.
Zymeworks (ZYME) Receivables - Net (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Receivables - Net across 6 years of filings, most recently posting $4.7 million for Q1 2026.
- Receivables - Net for Q1 2026 came in at $4.7 million, down 81.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.7 million (down 81.0% YoY), and the FY2025 annual result was $4.6 million, down 91.69% from the prior year.
- Receivables - Net came in at $4.7 million for Q1 2026 at Zymeworks, up from $4.6 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $67.3 million in Q3 2023 to a low of $2.6 million in Q2 2025.
- The 5-year median for Receivables - Net is $29.4 million (2025), against an average of $30.1 million.
- Across the five-year window, Receivables - Net soared 899.9% in 2023 and plunged 91.8% in 2025, its largest moves.
- Zymeworks' Receivables - Net stood at $33.4 million in 2022, then plunged by 41.69% to $19.5 million in 2023, then soared by 186.57% to $55.8 million in 2024, then plunged by 91.69% to $4.6 million in 2025, then rose by 0.78% to $4.7 million in 2026.
- The last three Receivables - Net figures came in at $4.7 million (Q1 2026), $4.6 million (Q4 2025), and $29.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.67 Mn |
| Mar 31, 2026 | 4.67 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 29.35 Mn |
| Sep 30, 2025 | 29.35 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Mar 31, 2025 | 24.59 Mn |
| Mar 31, 2025 | 24.59 Mn |
| Dec 31, 2024 | 55.82 Mn |
| Dec 31, 2024 | 55.82 Mn |
| Sep 30, 2024 | 23.70 Mn |
| Sep 30, 2024 | 23.70 Mn |
| Jun 30, 2024 | 32.08 Mn |
| Jun 30, 2024 | 32.08 Mn |
| Mar 31, 2024 | 30.95 Mn |
| Mar 31, 2024 | 30.95 Mn |
| Dec 31, 2023 | 19.48 Mn |
| Dec 31, 2023 | 19.48 Mn |